Risks of HRT
3 min read · Updated 27 March 2025

What are the risks of HRT for menopause?
HRT risks vary depending on the hormones used, how they are taken, treatment duration, age and overall health. Potential concerns include breast cancer, blood clots and cardiovascular disease, but medical guidelines indicate that benefits such as symptom relief and bone protection generally outweigh the risks, particularly for women who experience early menopause. An individual assessment with a Menopause Specialist helps put these risks into context.
- HRT risks depend on treatment type, duration and your personal health.
- Benefits generally outweigh risks, especially after early menopause.
- A specialist assessment considers your age, family history and overall health.
Medical Guidelines on HRT
Medical guidelines indicate that the benefits of HRT, such as quality of life improvements and bone health protection, generally outweigh the risks. This holds especially true for women who experience menopause early.
The risks associated with HRT are typically minimal and vary based on the type of HRT, its duration, and other factors like age and overall health.
HRT comes in various types and administration methods. The primary hormones in HRT are estrogen and progesterone. Estrogen plays a pivotal role in alleviating your symptoms, primarily caused by its deficiency. The optimal method for estrogen intake is transdermally.
Progesterone or a progestogen is recommended for women with an intact uterus who are also taking estrogen. This combination ensures the womb lining remains thin and healthy, countering estrogen’s potential to thicken it. Options for progesterone intake include tablets or the Mirena coil, which can last for 5 years.
Testosterone is another hormone some women may need, particularly for symptoms like low libido, energy deficiency, and concentration issues.
As of 2024, new research has proven that HRT is safe option and the gold-standard treatment of menopause.
Risk of Breast Cancer with HRT
While HRT offers numerous benefits, it’s essential to be informed about potential risks, like breast cancer. However, most HRT types don’t elevate breast cancer risk. BioConnect exclusively utilises BioIdentical Progesterone, which hasn’t been linked to increased breast cancer risk.
Although some studies suggest that combined HRT (estrogen and synthetic progestogen) might be associated with a slightly elevated breast cancer risk, this increase is duration-dependent and diminishes post-HRT. BioConnect opts for bioidentical progesterone over synthetic variants.
To put things in perspective, frequent alcohol consumption or being overweight both heighten the breast cancer risk more than synthetic progestogens.
Research hasn’t found any HRT type that increases breast cancer mortality rates.
Women taking only estrogen post-hysterectomy face no augmented breast cancer risk. Similarly, women under 51 years of age on any HRT type are not at an elevated risk.
Breast cancer, being relatively common, is present in many families’ medical histories. Yet, only about 10% of annual breast cancer diagnoses are attributed to genetic or familial causes. Existing evidence doesn’t suggest that familial breast cancer history amplifies the risk for HRT users compared to those without such a history.
Most women with familial breast cancer histories don’t develop the condition, irrespective of HRT usage.
Considering the numerous factors influencing HRT risk, it’s vital to consult with a Menopause Specialist at BioConnect for a personalized assessment.
Blood Clot Risk
BioConnect provides estrogen HRT in various forms, such as patches, gels, creams, sprays, or sub-dermal implants, none of which elevate blood clot risk. Some outdated oral HRT types posed this risk, emphasizing the importance of consulting Menopause Specialists updated with the latest research.
BioIdentical Progesterone, unlike older synthetic progestins, doesn’t elevate blood clot risk, making it a safer choice.
Cardio-Vascular Disease Risk
Starting HRT before the age of 60 doesn’t significantly increase cardiovascular disease risk and might even reduce it. Tablet-based HRT is linked to a minor stroke risk increase, but the risk for women below 60 remains low. BioConnect, therefore, offers estrogen HRT in transdermal forms like patches, gels, creams, sprays, or implants.
Post-menopause, women often notice a shift in body shape, leading to potential insulin resistance and diabetes, both heart disease precursors. HRT can counteract these effects, and estrogen even has vascular anti-inflammatory properties and can lower cholesterol.
Blood pressure often rises with age. Monitoring blood pressure and maintaining overall health can reduce heart disease risk. HRT, especially estrogen delivered transdermally, can even lower blood pressure. While some progestogens might elevate it, bioidentical progesterone seems neutral or even beneficial.
Your Menopause Specialist will assess all heart disease risk factors before prescribing any HRT, considering factors like age, family history, overall health, smoking habits, and womb status.
Sources for further information:
Understanding the Risks of HRT
How BioConnect can help
BioConnect’s Menopause Specialists can help you understand HRT options in the context of your symptoms, medical history and overall health. Book a consultation for a personalised assessment and a conversation about the potential benefits and risks.
Why BioConnect: menopause specialists, members of the Menopause Society, and gynaecology, skin, weight and hormone care together under one roof in Barbados.
Common questions
Why is progesterone prescribed alongside oestrogen?
Women who have a uterus are recommended progesterone or a progestogen alongside oestrogen to keep the womb lining thin and healthy, countering oestrogen’s potential to thicken it.
Does the duration of HRT affect breast cancer risk?
The article describes a possible slight increase in breast cancer risk with combined oestrogen and synthetic progestogen treatment. This increase depends on treatment duration and diminishes after HRT is stopped.
What will a Menopause Specialist consider before prescribing HRT?
The assessment includes your age, family history, overall health, smoking habits and whether you have a uterus. Your specialist will also assess heart disease risk factors before prescribing treatment.
This article is general information and not a substitute for personal medical advice.
Keep reading

Hormone Testing in Menopause and beyond: What’s the Truth?
Hormone testing is not routinely needed to confirm menopause, and fluctuating oestradiol and progesterone levels can make testing unhelpful during perimenopause. Its value depends on your age, symptoms, medications and treatment goals, while other blood tests may help identify factors contributing to symptoms and assess your broader health.

Diagnosis of Menopause
Menopause is diagnosed after 12 consecutive months without a period. Signs and symptoms usually identify the transition into menopause, and hormone tests are not typically needed to diagnose perimenopause because hormone levels fluctuate significantly. Tests may help assess premature menopause, exclude other causes of symptoms, or guide and monitor hormone treatment.

Understanding Menopause: A Guide to Managing the Transition
Perimenopause brings fluctuating hormone levels and may cause hot flushes, night sweats, vaginal dryness, mood changes and disrupted sleep. As periods stop during menopause, symptoms vary widely between women. Regular exercise, a nutritious diet, stress management and treatments discussed with a doctor can help manage the transition.
